Immunai will generate a publicly accessible multi-omic dataset for a Parker Institute cohort of over 1,000 cancer patients.

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ's dense tissue to define the margins between malignant and normal tissue. A new study uses DNA origami ...

A new study reveals that the protein alpha-synuclein, known for its role in Parkinson’s disease, also contributes to the ...

When the Dana Farber Cancer Institute announced that it was opening a new, $1.7 billion, 300-bed inpatient cancer hospital in ...

A small protein involved in neurodegeneration leading to Parkinson's disease also drives a type of skin cancer known as melanoma, according to new research.

A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

Teddi Mellencamp’s life is hanging in the balance as she battles an aggressive form of Stage 4 skin cancer. The “Real Housewives of Beverly Hills” star revealed this week that her dad ...

Dr. Tom Sellers, who has served as director of the OHSU Knight Cancer Institute for the past year, has resigned. Sellers took the reins of the institute last March, when Dr. Brian Druker changed r ...

This program provides a mechanism for cancer drug development that is in the public interest and that would not be performed with industry resources alone. The drugs that enter the NCI-IND program ...

This is a critical step forward for any new vaccine. Dr. G. Thomas Budd, a staff physician at the Cleveland Clinic Cancer Institute and principal investigator of the study, presented the findings ...

The director of Oregon Health & Science University’s $1 billion Knight Cancer Institute resigned this week after just one year on the job, leaving OHSU with yet another interim leader in a key role.